Esketamine - Focal Point Virtual Group Inc.

Esketamine

Spravato Billing Alert: Navigating the 2026 Shift from S0013 to J0013

Spravato Billing Alert: Navigating the 2026 Shift from S0013 to J0013 For mental health practices providing Spravato (esketamine), the administrative landscape just shifted. Effective January 1, 2026, the Healthcare Common Procedure Coding System (HCPCS) has undergone a significant update: the longstanding code S0013 has been discontinued and replaced with J0013 (Esketamine, nasal spray, 1 mg). […]

Spravato Billing Alert: Navigating the 2026 Shift from S0013 to J0013 Read More »

Spravato Treatment: What You Need to Know

Comprehensive Guide to Providing Spravato Services for Mental Health Providers Mental health providers play a critical role in helping patients navigate treatment options for conditions like treatment-resistant depression (TRD). One innovative option gaining attention is esketamine, marketed under the brand name Spravato. This guide will walk you through everything you need to know about providing

Spravato Treatment: What You Need to Know Read More »

Focal Point Virtual Group

Focal Point is a business-to-business that was founded to help medical practices increase access to care while maintaining autonomy. We pair you with tools to help boost your practice, whether it be a virtual assistant, billing and credentialing services, or other roles such as a ketamine/TMS intake coordinator. 

Facebook Instagram Linkedin

Links

Contact Us

  • (+1) 561 861 1787​
  • inquiry@thefocalpoint.info

Location

  • Head Office: 16192 Coastal Highway Lewes, DE 19958, Sussex County
  • Mailing Address: 11582 SW Village Pkwy #1063 Port Saint Lucie, FL 34987​
Share your feedback

© Focal Point 2025 | All Rights Reserved